<div id="readability-page-1"><p><span>Establishment Labs (NASDAQ:ESTA - Get Free Report)</span> had its price objective hoisted by stock analysts at JPMorgan Chase &amp; Co.  from $71.00 to $80.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an &#34;overweight&#34; rating on the stock. JPMorgan Chase &amp; Co.'s price target suggests a potential upside of 7.66% from the stock's previous close.</p><p>Several other equities research analysts have also commented on ESTA. Weiss Ratings  restated a &#34;sell (e+)&#34; rating on shares of Establishment Labs in a research report on Monday. Canaccord Genuity Group  set a $85.00 price objective on shares of Establishment Labs in a report on Wednesday. Mizuho increased their target price on shares of Establishment Labs from $85.00 to $90.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday. BTIG Research lifted their price target on shares of Establishment Labs from $70.00 to $81.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, November 14th. Finally, Citigroup upped their price target on Establishment Labs from $62.00 to $75.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, December 11th. Six analysts have rated the stock with a Buy rating, one  has issued  a Hold rating and one  has issued  a Sell rating to the stock. Based on data from MarketBeat.com, the company  has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $78.14.</p><div><p><span></span><span>Get <strong>Establishment Labs</strong> alerts:</span></p></div><p><b>Get Our Latest Report on Establishment Labs</b></p><h2>Establishment Labs Stock Performance</h2><p>NASDAQ:ESTA traded up $0.16 during mid-day trading on Wednesday, reaching $74.31. The stock had a trading volume of 512,662 shares, compared to its average volume of 494,735. Establishment Labs has a twelve month low of $26.56 and a twelve month high of $78.24. The business has a 50 day simple moving average of $59.72 and a 200 day simple moving average of $47.10. The firm has a market capitalization of $2.16 billion, a price-to-earnings ratio of -26.10 and a beta of 1.01. The company has a debt-to-equity ratio of 15.06, a quick ratio of 2.10 and a current ratio of 3.33. </p><p>Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.54) by $0.16. The company had revenue of $53.78 million for the quarter, compared to analysts' expectations of $52.28 million. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.The firm's quarterly revenue was up 33.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.59) EPS.  On average, analysts expect that  Establishment Labs will post -2.41 earnings per share for the current fiscal year. </p><h2>Institutional Trading of Establishment Labs</h2><p>A number of hedge funds have recently added to or reduced their stakes in ESTA. Affinity Asset Advisors LLC raised its position in shares of  Establishment Labs by 19.6% in the 2nd quarter. Affinity Asset Advisors LLC now owns 334,863 shares of the company's stock valued at $14,302,000 after purchasing an additional 54,863 shares in the last quarter.  Mudita Advisors LLP increased its stake in shares of  Establishment Labs by 15.6% in the first quarter. Mudita Advisors LLP now owns 479,359 shares of the company's stock worth $19,560,000 after buying an additional 64,859 shares during the last quarter.  Milestone Asset Management LLC acquired a new stake in  Establishment Labs in the second quarter valued at $523,000.  Hood River Capital Management LLC boosted its stake in  Establishment Labs by 138.2% during the 2nd quarter. Hood River Capital Management LLC now owns 53,124 shares of the company's stock valued at $2,269,000 after acquiring an additional 30,825 shares during the last quarter.  Finally, Swiss National Bank grew its holdings in  Establishment Labs by 1.3% during the 1st quarter. Swiss National Bank now owns 39,000 shares of the company's stock worth $1,591,000 after acquiring an additional 500 shares in the last quarter. 72.91% of the stock is owned by institutional investors and hedge funds. </p><h2>About Establishment Labs</h2> (Get Free Report)<p>Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Establishment Labs</li><li>Insider Trading - What You Need to Know</li><li>Is Tesla Overvalued? 2 Reasons It Might Be a Bargain</li><li>What is Forex and How Does it Work? </li><li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li><li>Quiet Period Expirations Explained</li><li>Intel Snaps Up AI Tech for Pennies on the Dollar</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RVNUQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RVNUQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Establishment Labs Right Now?</h2><p>Before you consider Establishment Labs, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.</p><p>While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ESTA

<p>JPMorgan Chase & Co. raised its price target for Establishment Labs (NASDAQ:ESTA) from $71.00 to $80.00 and maintained an "overweight" rating, indicating a potential upside of 7.66%. Other analysts have mixed ratings, with some increasing their price targets and others maintaining a "sell" rating. Establishment Labs reported better-than-expected earnings for the last quarter and saw a 33.8% increase in revenue year-over-year. Institutional investors have shown increased interest in the stock.</p>

JPMorgan Chase & Co. Issues Positive Forecast for Establishment Labs (NASDAQ:ESTA) Stock Price